Programme JADE
Geneva, 1202, Switzerland
NCT Number: NCT04778163
Clinical study in psychiatry in young adult patients between 18 and 25 years old. The aim of the study is to evaluate the therapeutic impact of the clinical use of humor through 6 group sessions (group of 5 to 10 patients), at the rate of one hour session per week for 6 weeks.
The investigators will form 2 groups of 5 to 10 patients matched in terms of gender, education level and score on a scale measuring their sense of humor. The participants will be asked to complete a series of tests measuring their ability to use humor, psychiatric symptoms and well-being.
Group 1 (test group) will participate in the humor-based sessions, while Group 2 (control group) will receive regular treatment for 6 weeks (waiting list: patients in Group 2 will attend humor-based sessions once Group 1 has completed their 6 weeks).
At the end of the 6-week sessions, both groups will receive the same series of pre-session tests to see whether or not there has been improvement in their overall functioning, psychiatric symptomatology and appreciation/use of humor.
At the end of the 2x 6-week sessions, group 2 will again receive this series of pre-session tests to see whether or not their overall functioning, psychiatric symptomatology and appreciation/use of humour has improved.
Objective(s)/Aim:
To evaluate the resilience of young adult psychiatric patients and their ability to cope with stress through the use of humor in a set of 6 modules on the use of humor.
To evaluate the symptoms.
Outcome/Endpoints :
Using scales, measure this evolution.
Looking for future studies?
Notify Me18 year–25 year
All sexes
Interventional
Not applicable
Geneva, 1202, Switzerland
Project design and procedures :
The investigators will form 2 groups of 5 to 10 patients matched on their score on the sense of humor scale, their gender and their level of education. The participants will be asked to complete a series of tests measuring their ability to use humor, clinical variables and general functioning.
Group 1 - experimental - will participate in a "humor group" with a one-hour group session per week for 6 weeks.
Group 2 - the control group - will follow a usual treatment regimen for 6 weeks. At the end of the "Humor Group" of group 1, the 2 groups of patients will undergo a second series of tests identical to those of the pregroup. The paired patients should be randomly assigned. The control group will do the "Humor Group" after 6 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Clinical study in psychiatry in young adult patients between 18 and 25 years old. The aim of the study is to evaluate the therapeutic impact of the clinical use of humor through 6 group sessions (group of 5 to 10 patients), at the rate of one hour session per week for 6 weeks.
The investigators will form 2 groups of 5 to 10 patients matched in terms of gender, education level and score on a scale measuring their sense of humor. The participants will be asked to complete a series of tests measuring their ability to use humor, psychiatric symptoms and well-being.
Other names: Treatment, Group psychotherapy
Time frame: About three years
To evaluate whether or not their appreciation/use of humor has improved.
Time frame: About three years
To evaluate whether or not the coping evolution has improved.
Time frame: About three years
To evaluate whether or not the overall psychiatric symptomatology has improved.
Time frame: About three years
To evaluate whether or not the overall functioning has improved.
Time frame: About three years
To evaluate whether or not the overall global clinical impression has improved.
University Hospital, Geneva
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05282173
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Cape Town, Western Cape, South Africa
View Trial DetailsNCT07445802
Behavior, Bipolar Disorder
View Trial DetailsNCT07708701
Behavior, Brain Diseases
Van, Turkey (Türkiye)
View Trial DetailsNCT07045441
Behavior, Behavioral Counseling
Al Mansurah, Dakahlia Governorate, Egypt
View Trial Details